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Cardiology
Heart
Blood vesselsA new journal has been launched: IJC — Heart and Vessels [1]. It builds upon the success of the main journal Inter-
national Journal of Cardiology. As an introduction to the new journal we will be publishing a series of summaries of
the topics to be covered, highlighting themost important papers in theﬁeld that have beenpublished recently in the
main journal, International Journal of Cardiology. This article describes a topic review of congenital heart disease. IJC
has become one of the most important sources of quality papers in this ﬁeld and many excellent publications have
been published in themain journal. The expansion of space occasioned by the launch of IJC—Heart and Vessels will
allow us to publish more high quality papers in the expanding ﬁeld of congenital heart disease.
© 2013 The Authors. Published by Elsevier Ireland Ltd. Open access under CC BY-NC-ND license.Cardiovascular manifestations of mucopolysaccharidosis type VI
(Maroteaux–Lamy syndrome)
The aim of the article is to gather and summarize the published
data about the incidence, course of illness, treatment possibilities
and complications of cardiovascular disorders in patients with
mucopolysaccharidosis type VI (MPS VI) also known as Maroteaux–
Lamy syndrome. MPS VI is a lysosomal storage disorder caused by deﬁ-
cient activity of N-acetylogalactosamine-4-sulfatase leading to progres-
sive intracellular accumulation of glycosaminoglycans. The relatively
low birth prevalence ranging from 1 in 43,000 to 1 in 1.5 million births
mirrors the limited descriptions of the cardiovascular disorders in the
medical literature. Patients with MPS VI can be speciﬁcally treated
with enzyme replacement therapy. Extra-cardiac features include
growth retardation, coarse facial features, stiff joints, skeletal
malformations (dysostosis multiplex), respiratory problems, corneal
clouding, and hepatosplenomegaly. The clinical presentation varies
considerably, however the development of heart disease and cardiac
dysfunction is a serious problem in the majority of patients. The most
characteristic cardiac presentation is valvular disease, while other
MPS VI patients also develop cardiomyopathy, ﬁbroelastosis, pulmo-
nary hypertension, cardiac conduction system disorders and otherand University ofWarwick UK.
land Ltd. Open access under CC BY-NCcomplications. There are also reports on acute heart failure. Early car-
diovascular manifestation may escape detection since joint stiffness or
skeletal malformations limit maximal exercise levels and respiratory
system involvement may mask the underlining cardiac insufﬁciency.
A correct and timely diagnosis offers the possibility of disease-speciﬁc
treatment leading to sustained clinical beneﬁts for cardiac and non-
cardiac MPS VI manifestations [2].
Clinical outcomes of adult survivors of pulmonary atresia with
intact ventricular septum
Background
There are no studies on the long term clinical outcomes and compli-
cations in the adult patient with pulmonary atresia with intact ventric-
ular septum (PA/IVS). This study reviews our experience with a limited
group of adult survivors of PA/IVS seen in our adult congenital clinics.
Methods
Twenty adult patients with PA/IVS (1998 to 2009) were identiﬁed
fromMayo Clinic adult congenital heart disease databases. Surgical his-
tory and clinical outcomes were reviewed.
Results
Mean age at last evaluation was 29 years (19–39 years). There were
ﬁve deaths within the study period (1998–2009). Median age at death-ND license.
2 Editorialwas 32 years (30–37 years). Seven patients underwent the Fontan op-
eration, eight patients had a biventricular repair, and ﬁve patients
remained with palliative shunts. All patients required re-interventions
in adulthood. Tricuspid valve (TV) (n = 5), pulmonary valve (PV)/
conduit (n = 6), and mitral valve (n = 2) replacements were the
most frequent re-intervention in the biventricular repair subset. Atrial
arrhythmias were present in 80% of the total cohort, the highest rate
among Fontan repairs (n = 7) and biventricular repairs (n = 7).
Ventricular arrhythmias occurred in 15% of the cohort.
Conclusions
Although limited in number, the adult PA/IVS patients in this se-
ries continue to have high rates of morbidity and mortality, with ar-
rhythmias and need for re-operations as the major causes. Patients
with biventricular repairs had the highest re-intervention rate in
adulthood. While this subset of patients might not be representative
of all adult PA/IVS survivors, continued follow-up at centers with ex-
pertise in adult congenital cardiology is recommended for all pa-
tients [3].
Aortic and left ventricular remodeling in patientswith bicuspid aortic
valve without signiﬁcant valvular dysfunction: a prospective study
Background
Bicuspid aortic valve (BAV) represents the most common cardiac
congenital malformation in the adult age. It is frequently associated
with dilatation, aneurysm and dissection of the ascending aorta. The
purpose of the following study was to evaluate in patients with BAV:
1) the elastic properties of the ascending aorta, 2) the mechanical func-
tion of the left ventricle and 3) stiffness, elasticity and strain of the epi-
aortic vessels wall.
Methods
Forty BAV patients (28 M/12 F; age 20.9 ± 4.7 years; range 17–26)
with no or mild valvular impairment were recruited with 40 control sub-
jects (25 M/15 F; age 23.4 ± 3.4 years; range 15–31) matched for age,
gender and body surface area (BSA). Aortic strain, aortic distensibility
(AoDIS) and aortic stiffness index (AoSI) were derived. Left ventricular
strain was acquired. Elastic properties of epi-aortic vessels were
evaluated.
Results
BAVs vs. controls had increased systolic and diastolic aortic diame-
ters (p b 0.001). Aortic strain (%) was lower in BAVs than in controls
(8.3 ± 3.6 vs. 11.2 ± 2.6; p b 0.001) as well as AoDIS (10(−6)cm(2)
dyn(−1)) (6.5 ± 2.8 vs. 8.8 ± 2.9; p = 0.002), while AoSI was greater
in BAVs (6.4 ± 3.5 vs. 3.9 ± 1.2; p b 0.001). Both AoDIS and aortic
strain were related to aortic size in BAVs and controls. Left ventricular
longitudinal (p = 0.01), circumferential (p = 0.01) and radial
(p b 0.001) strains (%) were lower in BAVs. No signiﬁcant differences
were found in elastic properties of epi-aortic vessels.
Conclusions
Bicuspid aortic valve is associated with an increased aortic stiffness
andwith a reduction of the aortic and left ventricular deformation prop-
erties. Epi-aortic vessels do not seem to be interested by the disease. The
use of an echocardiographicmethod that can estimate thedegree of aor-
tic and left ventricular remodeling can provide great beneﬁts in the se-
lection of patients with BAV to be treated and in determining the time
for beginning drug therapy [4].Post-interventional three-dimensional dark blood MRI in the adult
with congenital heart disease
Background
Investigate a novel three-dimensional (3D) turbo spin echo (TSE)
magnetic resonance imaging (MRI) sequence to assess stented seg-
ments in adults with congenital heart disease (CHD) after transcatheter
intervention.
Methods
Adults with CHD referred for computed tomography (CT) after
transcatheter intervention underwent MR exam with a 3D respiratory
gated TSE sequence. Data obtained at the time of the study included
type of CHD, radiation dose, length of time between exams, and luminal
diameters of stented segments from each exam. Continuous variables
were analyzed using Student's t and Bland–Altman plots performed to
analyze measurements obtained from both examinations.
Results
Eleven patients underwent both examinations. Type of defects includ-
ed Coarctation of the Aorta (n = 6) and Tetralogy of Fallot. The average
radiation dose was 19.6 mSv and the average time between CT and MRI
was 99 ± 160 days. Luminal diameters of stented vessels correlated
closely between TSEMRI and CT (r(2) = .85) with a bias toward overes-
timation with MRI (mean 22.4 ± 4.3 mm and 20.9 ± 3.7 mm, p b .01).
Conclusion
This novel 3D respiratory gated TSE MR technique provides a feasi-
ble method to reduce metallic artifact and improve visualization of
stented segments and surrounding anatomic structures without expo-
sure to radiation [5].
Structure andprocessmeasures of quality of care in adult congenital
heart disease patients: a pan-Canadian study
Background
There are more adults than children with congenital heart disease.
Of over 96,000ACHDpatients in Canada, approximately 50% require on-
going expert care. In spite of published recommendations, data on the
quality of care for ACHD patients are lacking.
Methods
Survey methodology targeted all Canadian Adult Congenital Heart
(CACH) network afﬁliated ACHD centers. Clinics were asked to prospec-
tively collect outpatient and procedural volumes for 2007. In 2008, cen-
ters were surveyed regarding infrastructure, stafﬁng, patient volumes
and waiting times.
Results
All 15 CACH network registered centers responded. The total number
of patients followed in ACHD clinics was 21,879 (median per
clinic = 1132 (IQR: 585, 1816)). Of the total 80 adult and pediatric cardi-
ologists afﬁliated to an ACHD clinic, only 27% had received formal ACHD
training.Waiting times for non-urgent consultationswere 4 ± 2 months,
and 4 ± 3 months for percutaneous and surgical procedures. Thesewere
beyond Canadian recommended targets at 11 sites (73%) for non-urgent
consultations, at 8 sites (53%) for percutaneous interventions and 13
sites (87%) for surgery.
3EditorialConclusions
Of a minimum number of 96,000 ACHD patients in Canada, only
21,879 were being regularly followed in 2007. At most sites waiting
times for ACHD services were beyond Canadian recommended targets.
In spite of universal health care access, published guidelines for ACHDpa-
tient structure and process measures of health care quality are not being
met [6].
Factors associated with surgery for active endocarditis in congenital
heart disease
Background
Despite the recent progress of cardiac surgery, the indications for
surgical intervention during the active phase of infective endocarditis
have not yet been established in patients with congenital heart diseases
due to the limited number of such patients. The present study aims to
determine the surgical indications for active infective endocarditis in
congenital heart diseases.
Methods
A retrospective observational cohort multi-center study on infective
endocarditis with congenital heart diseases was conducted from Janu-
ary 1997 to December 2001 in Japan and 239 patients were registered.
Sixty-one (26%) of the 239 patients had undergone surgical therapy
for active infective endocarditis, which was deﬁned as cardiac surgery
during administration of intravenous antibiotics.
Results
Therewere 7 deaths (11%). A univariate regression analysis revealed
that the factors signiﬁcantly associated with the need for surgical inter-
vention for active IE were the lack of diagnosis of cardiac disorders
before the onset of infective endocarditis, aortic valve infective endocar-
ditis, perivalvular abscess, presence of heart failure, and change of anti-
biotics. A stepwise logistic regression analysis revealed that the
presence of a perivalvular abscess, and heart failure and a change in
the antibiotics were independent determinant factors for the need for
surgical treatment of active infective endocarditis in patients with con-
genital heart diseases.
Conclusions
Surgery should therefore be considered even during the active phase
in patients with congenital heart diseases and infective endocarditis,
when they develop associated with heart failure, a perivalvular abscess,
or the need for a change in antibiotics [7].
The applications of non-ECG-gated MSCT angiography in children
with congenital heart disease
Background
To minimize radiation exposure during a multi-slice computed
tomography (MSCT) examination in children with congenital heart
disease (CHD), we assessed diagnostic value and the various applica-
tions of MSCT without electrocardiography (ECG)-gated image
acquisition.
Methods
Three-dimensional (3D) images were reconstructed to include vol-
ume rendering and differential color-coding of the arteries and veins.
The vessel diameter inMSCTwasmeasuredwith CT attenuation proﬁlesand compared with that of angiography. Ventricular volumetry was
initially validated by phantom experiment and followed by compar-
ison with that of cine-angiography (n = 15). Simulation for surgical
operation was performed to evaluate the possibility of an intraven-
tricular conduit in patients diagnosed with a double outlet right
ventricle.Results
Differential color-coding was able to provide accurate and under-
standable anatomical structure in CHD. The diameter of the descending
aortameasured inMSCT correlatedwell with the values obtained by an-
giography (r(2) = 0.86). According to the results of the phantom ex-
periment, ventricular volume was studied in patients whose heart
ratewas faster than 120 beat/min. The left and the right ventricular vol-
umes in MSCT correlated well with values obtained by cine-
angiography (r(2) = 0.98 for RV, r(2) = 0.94 for LV). Simulative oper-
ation of intraventricular rerouting provided appropriate indication for
biventricular repair in patients diagnosed with a double outlet right
ventricle.Conclusions
Non-ECG-gatedMSCT angiography is applicable for precise anatom-
ical diagnosis, ventricular volumetric study, and simulation surgery in
children with CHD [8].Hypoxia in early life is associated with lasting changes in left
ventricular structure and function at maturity in the rat
Background
There is a growing population of adults with repaired cyanotic con-
genital heart disease. These patients have increased risk of impaired
cardiac health and premature death. We hypothesized that hypoxia in
early life before surgical intervention causes lasting changes in left ven-
tricular structure and function with physiological implications in later
life.Methods
Sprague–Dawley rats reared initially hypoxic conditions (FiO(2) =
0.12) for days 1–10 of lifewere compared to rats reared only in ambient
air. Cellular morphology and viability were compared among LV
cardiomyocytes and histological analyses were performed on LV
myocardium and arterioles. Intracellular calcium transients and cell
shortening were measured in freshly-isolated cardiomyocytes, and mi-
tochondrial hexokinase 2 (HK2) expression and activity were deter-
mined. Transthoracic echocardiography was used to assess LV function
in anesthetized animals.Results
Cardiomyocytes from adult animals following hypoxia in early life
had greater cellular volumes but signiﬁcantly reduced viability. Echo-
cardiographic analyses revealed LV hypertrophy and diastolic dysfunc-
tion, and alterations in cardiomyocyte calcium transients and cell
shortening suggested impaired diastolic calcium reuptake. Histological
analyses revealed signiﬁcantly greater intima-media thickness and de-
creased lumen area in LV arterioles from hypoxic animals. Alterations
in mitochondrial HK2 protein distribution and activity were also ob-
served which may contribute to cardiomyocyte fragility.
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Hypoxia in early life causes lasting changes in left ventricular struc-
ture and function that may negatively inﬂuence myocardial and vascu-
lar responses to physiological stress in later life. These data have
implications for the growing population of adults with repaired or pal-
liated cyanotic congenital heart disease [9].
End-of-life in adults with congenital heart disease: a call for early
communication
Background
We investigated preferences of adults with congenital heart disease
(CHD) and their health care providers regarding end-of-life (EOL)
communication.
Methods
Adult CHD outpatients and health care providers completed surveys
about preferences for and experiences with EOL communication. Re-
sponses were compared between patients and providers.
Results
Two hundred patients (18–79 years) and 48 CHD health care pro-
viders (primarily cardiologists) completed surveys. Only 2 patients
(1%) indicated that they had discussed EOL planningwith their medical
team. In contrast, 50% of providers reported that they typically discuss
issues including life expectancy, advance planning, and resuscitation
preferences with their outpatients. Seventy-eight percent (156/199)
of patients wanted their medical team to raise EOL issues; this prefer-
ence was independent of disease complexity and socio-demographic
factors. In contrast, providers reported that their EOL discussions in-
crease in accordance with disease complexity (p b 0.001). Early initia-
tion of EOL discussions, before diagnosis with life-threatening
complications, was favored by 62% of patients but only 38% of providers
(p b 0.001).
Conclusion
Health professionals caring for adultswith CHD should explore pref-
erences of their patients for EOL discussions earlier in the disease
course, and not only with patients facing life-threatening complications
and/orwith complex conditions.When EOLdiscussions do occur, health
care providers should attempt to ensure that patients better understand
these conversations. Increased attention to EOL issues is proposed in
order to improve the care of patients with CHD across the lifespan [10].
Bosentan–sildenaﬁl association in patients with congenital
heart disease-related pulmonary arterial hypertension and
Eisenmenger physiology
Objectives
The aim of the present study was to evaluate the safety, tolerability,
and clinical and haemodynamic impacts of add-on sildenaﬁl in patients
with congenital heart disease (CHD)-related pulmonary arterial hyper-
tension (PAH) and Eisenmenger physiology after failure of oral bosentan
therapy.
Methods
Thirty-two patients with CHD-related PAH (14 male, mean age
37.1 ± 13.7 years) treated with oral bosentan underwent right heart
catheterization (RHC) for clinical worsening. After RHC, all patientsreceived oral sildenaﬁl 20 mg thrice daily in addition to bosentan.
Clinical status, resting transcutaneous oxygen saturation (SpO(2)),
6-minute walk test (6MWT), serology and RHC were assessed at
baseline (before add-on sildenaﬁl) and after 6 months of combina-
tion therapy.Results
Twelve patients hadventricular septal defect, 8 atrio-ventricular canal,
6 single ventricle, and 6 atrial septal defect. 28/32 had Eisenmenger phys-
iology and 4 (all with atrial septal defect) did not. All patients well toler-
ated combination therapy. After 6 months of therapy, an improvement in
clinical status (WHO functional class 2.1 ± 0.4 vs 2.9 ± 0.3; p = 0.042),
6-minute walk distance (360 ± 51 vs 293 ± 68 m; p = 0.005), SpO(2)
at the end of the 6MWT (72 ± 10 vs 63 ± 15%; p = 0.047), Borg score
(2.9 ± 1.5 vs 4.4 ± 2.3; p = 0.036), serology (pro-brain natriuretic pep-
tide 303 ± 366 vs 760 ± 943 pg/mL; p = 0.008) and haemodynamics
(pulmonary blood ﬂow 3.4 ± 1.0 vs 3.1 ± 1.2 L/min/m(2), p = 0.002;
pulmonary vascular resistances index 19 ± 9 vs 24 ± 16 WU/m(2),
p = 0.003) was observed.Conclusions
Addition of sildenaﬁl in adult patients with CHD-related PAH and
Eisenmenger syndrome after oral bosentan therapy failure is safe
and well tolerated at 6-month follow-up, resulting in a signiﬁcant
improvement in clinical status, effort SpO(2), exercise tolerance
and haemodynamics [11].Right ventricular–left ventricular interaction in adults with
Tetralogy of Fallot: a combined cardiac magnetic resonance and
echocardiographic speckle tracking study
Objectives
To assess ventricular dysfunction and ventricular interaction after
repair of Tetralogy of Fallot (ToF) employing echocardiography
speckle-tracking and cardiac magnetic resonance imaging (CMR).Background
Severe pulmonary regurgitation and right ventricular (RV) dysfunc-
tion are common after repair of ToF and may also affect the shape and
function of the left ventricle (LV). Recent studies suggest that LV dys-
function may be of particular prognostic value.Methods and results
Twenty-one consecutive adults with repaired ToF (15 male, mean
age 38 ± 11 years, 7 with severe PR) underwent a comprehensive
echocardiographic exam including speckle-tracking analysis, CMR
and cardiopulmonary exercise testing. Twenty-one subjects without
relevant heart disease served as controls. Echocardiographically mea-
sured RV diameters correlated with RV volumes obtained from CMR
(r = 0.63; p = 0.006). In addition, a close correlation was found be-
tween RV and LV functions on CMR (r = 0.74, p = 0.002), speckle-
tracking LV and RV peak longitudinal 2D strain (r = 0.66,
p = 0.003) and mitral and tricuspid annular plain systolic excursion
(r = 0.71, p = 0.0003). While LV ejection fraction was normal in
the majority of patients and not different from controls, LV longitudi-
nal strain was signiﬁcantly reduced in ToF patients (−16.5 ± 3.3 vs.
−20.5 ± 2.7%, p = 0.0001).
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Left and right ventricular function both by CMR and speckle-
tracking is interrelated in adults with repaired ToF. Despite normal
LV ejection fraction, 2D longitudinal strain is signiﬁcantly reduced
in ToF patients, suggesting subclinical LV myocardial damage. Con-
sidering the potential prognostic value of LV dysfunction in ToF, this
measurement may gain importance and should be included in future
outcome studies [12].Outcome of direct current cardioversion for atrial arrhythmias in
adults with congenital heart disease
Objectives
We sought to evaluate safety, efﬁcacy, and outcome of direct current
cardioversion (DCCV) for atrial arrhythmias in adults with congenital
heart disease (CHD).Background
Atrial arrhythmias are increasingly noted in adults with CHD. The
outcome of DCCV for atrial arrhythmias in this population is
unknown.Methods
Our study was a retrospective review of patients 18 years or older
with CHD who underwent DCCV between June 2000 and July 2003.
This constituted the CHD group. Patient characteristics reviewed includ-
ed the speciﬁc cardiac diagnosis and arrhythmia history. A subset of pa-
tients had transesophageal echocardiography (TEE) before DCCV; this
subset was reviewed to evaluate spontaneous echocardiographic
contrast. The outcome data evaluated included success of DCCV, compli-
cations, recurrence of arrhythmia, antiarrhythmic medication use, elec-
trophysiology or pacemaker procedure in follow-up, and all-cause
mortality. The recurrence rate of the arrhythmiawas compared to a con-
trol group consisting of an age, gender, and rhythm matched group of
patients who have no CHD and who underwent DCCV for atrial
arrhythmias.Results
Sixty-three patients in the CHD group underwent 80 DCCVs, 59 of
which were TEE-guided. Atrial ﬂutter was more common in the CHD
group (37 of 80 DCCV, 46%) than in the control group (13 of 56, 23%)
(p b 0.001). DCCV was successful in 75 (94%). Mean follow-up was
387 days. No thromboembolic events were noted. All-cause mortality
on follow-up was 11%. There was no death related to DCCV. Twenty-
ﬁve patients in the CHD group (40%) remained in sinus rhythm
throughout follow-up. This was similar to that observed in the control
group (30/56, 54%, p = 0.13). Recurrent arrhythmia in the CHD group
was predicted by the presence of atrial ﬁbrillation (p = 0.009) and
less so spontaneous echo contrast in the left atrium (p = 0.05).Conclusions
DCCV with appropriate anticoagulation is safe and effective for pa-
tientswith CHD, even in thepresence of an intracardiac shunt and spon-
taneous contrast on TEE. However, the recurrence rate is substantial.
Spontaneous echo contrast in the left atrium along with atrial ﬁbrilla-
tion predicts arrhythmia recurrence following DCCV in patients with
CHD [13].Circumstances of death in adult congenital heart disease
Background
Circumstances of death have been described for various cardiovascu-
lar diseases, but this study is the ﬁrst for adults with congenital heart dis-
ease (CHD).
Methods
Review of medical records and additional information from treating
cardiologists and general practitioners, for circumstances of all deaths in
a national registry of over 8000 adults with CHD.
Results
Of 8595 patients, 231 (2.7%) patients died over 26,500 patient
years. Main causes of death were progressive heart failure (26%) and
sudden cardiac death (22%). Mortality was highest in the northern,
most rural region of the country (p ≤ 0.05). Overall, death occurred
out-of-hospital in approximately 35%, but more frequently in rural
than in urban areas (55% versus 32%, p ≤ 0.05). Mortality was almost
equally distributed throughout the seasons, although fall showed a
slightly higher mortality rate. Cardiovascular death occurred suddenly
in nearly 40%. Sudden cardiovascular death occurred in 8% during exer-
cise, andmost often out-of-hospital (62%). Of non-sudden cardiovascu-
lar deaths 18% had occurred out-of-hospital.
Conclusion
In adult patients with congenital heart disease, mortality shows
substantial regional and subtle seasonal variation. Death usually oc-
curs at rest; approximately 1 of 10 sudden cardiovascular deaths oc-
curs during exercise [14].
Minor symptoms of depression in patients with congenital
heart disease have a larger impact on quality of life than
limited exercise capacity
Objective
In patients with congenital heart disease quality of life is only mar-
ginally associated with exercise capacity. The aim of this study was to
determine the prevalence of depression and its impact on quality of
life and exercise capacity.
Patients and methods
From November 2007 to October 2009 a total of 767 patients (352
female, 14–67 years) with various congenital heart diseases (37 palliat-
ed/native cyanotic, 57 Fontan, 74 Transposition of the Great Arteries
(TGA) after atrial switch, 50 other TGA, 136 Fallot, 38 Ebstein, 47 Pul-
monic stenosis/regurgitation, 68 aortic coarctation, 103 aortic steno-
sis, 90 isolated shunts, 67 other) completed the health-related
quality of life questionnaire SF-36 and the German translation of
the “Center for Epidemiologic Studies Depression Scale” (CES-D) to
assess depressive symptoms. Afterwards a cardiopulmonary exer-
cise test was performed.
Results
Only 66 patients (8.6%) showed depressive symptoms fulﬁlling the
CES-D deﬁnition for depression. The total prevalence of depression
was lower than in the general population (Wilcoxon test, p b 0.001)
and did not differ substantially in between the diagnostic subgroups
(Kruskal–Wallis test, p = 0.195). CES-D score was correlated to all of
6 Editorialthe nine dimensions of quality of life (r = −0.170 to r = −0.740,
p b 0.001) and less pronounced to exercise capacity (r = −0.164,
p b 0.001). Correlation of peak oxygen uptake to quality of life was
weaker than the CES-D scores in all subscales of life quality.Conclusions
Patients with congenital heart disease are rarely depressive. Howev-
er, even minor depressive symptoms have a stronger impact on quality
of life than limited exercise capacity as seen in many patients [15].Validation of an animal model of right ventricular dysfunction and
right bundle branch block to create close physiology to postoperative
tetralogy of Fallot
Background
In the past 5 years a few number of studies and case reports have
come out focusing on biventricular (BiV) stimulation for treatment of
congenital heart disease related ventricular dysfunction. The few avail-
able studies include a diverse group of pathophysiological entities rang-
ing from a previously repaired tetralogy of Fallot (ToF) to a functional
single ventricle anatomy. Patient's status is too heterogeneous to build
important prospective study. To well understand the implication of
prolonged electromechanical dyssynchrony we performed a chronic
animal model that mimics essential parameters of postoperative ToF.Methods
Signiﬁcant pulmonary regurgitation, mild stenosis, as well as right
ventricular outﬂow tract (RVOT) scars were induced in 15 piglets to
mimic repaired ToF. 4 months after hemodynamics and dyssynchrony
parameters were comparedwith a control group andwith a population
of symptomatic adult with repaired ToF.Results
Comparing the animal model with the animal control group on
echocardiography, RV dilatation, RV and LV dysfunction, broad QRS
complex and dyssynchrony was observed on the animal model piglets.
Moreover, epicardial electrical mapping showed activation consistent
with a right bundle branch block. The animal models displayed the
same pathophysiological parameters as the post ToF repair patients in
terms of QRS duration, pulmonary regurgitation biventricular dysfunc-
tion and dyssynchrony.Conclusion
This chronic swine model mimics electromechanical ventricular ac-
tivation delay, RV and LV dysfunction, as in adult population of repair
ToF. It does appear to be a very useful and interesting model to study
the implication of dyssynchrony and the interest of resynchronization
therapy in ToF failing ventricle [16].Measures of exercise capacity in adults with congenital heart disease
Background
Exercise capacity in grown-ups with congenital heart disease
(GUCH) is mostly reported by peak oxygen consumption (peak
VO(2)). Our aim was to evaluate the maximal character of exercise
tests, and to investigate submaximal measures of exercise capacity.Methods
Adults with Coarctation of the Aorta (CoA, n = 155), Tetralogy of
Fallot (ToF, n = 98), dextro-Transposition of the Great Arteries (dTGA,
n = 68) andUniventricularHeart (UVH, n = 10), and 122healthy adults
performed cardiopulmonary exercise testing until exhaustion. Gas ex-
change was measured breath by breath. The maximal performance of
the test was evaluated by respiratory exchange ratio (RER), ventilatory
equivalent for oxygen and Borg scale. Oxygen uptake efﬁciency slope
(OUES), VE/VCO(2) slope and VO(2)/WR slope were calculated and
ventilatory anaerobic threshold (VAT) was deﬁned. Correlations of
these measures with peak VO(2) were calculated.
Results
GUCH showed signiﬁcantly lower peak VO(2) than controls
(p b 0.001), declining from 80% in COA, 74% in ToF, 64% in dTGA, to
55% in UVH. Compared to the suggested criteria, mean peak RER and
median Borg scale indicated a maximal effort in GUCH, however
these results were signiﬁcantly lower than controls (p b 0.05). OUES,
VO(2)/WR slope and VAT were signiﬁcantly lower in patients com-
pared to controls. OUES (r = 0.853) and VAT (r = 0.840) correlated
best with peak VO(2); VO(2)/WR slope (r = 0.551) and VE/VCO(2)
slope (r = −0.421) correlated to a lesser degree (p b 0.001).
Conclusion
The investigated GUCH show reduced exercise tolerance compared
to controls, related to the underlying heart defect. Different expressions
of exercise tolerance clearly reveal the same differences in exercise ca-
pacity across groups of GUCH [17].
The prevalence and risk factors for cholelithiasis and asymptomatic
gallstones in adults with congenital heart disease [18]
Purpose
Cyanosis is considered to be a risk factor for cholelithiasiswhich is an
important complication of cyanotic congenital heart disease (CCHD) in
adults. In this study, the prevalence of cholelithiasis and asymptomatic
calcium bilirubinate gallstones was evaluated in adults with congenital
heart disease (CHD). Furthermore, risk factors for this potentially high
risk complication were assessed.
Materials and methods
Subjects were derived from 114 consecutive congenital patients
who visited our center from May 2008 to January 2009. For analyses
of risk factors, we divided them into 4 groups: group A, 15 CCHD pa-
tients without reparative surgery (7 men, 31.8 ± 7.0 years old);
group B, 41 CCHD patients rendered acyanotic by reparative surgery (21
men, 32.5 ± 11.8 years old); group C, 23 unoperated acyanotic CHD pa-
tients (11 men, 42.4 ± 16.4 years old); and group D, 35 patients who
were acyanotic before and after operation (18 men, 36.3 ± 14.8 years
old). Gallstones were identiﬁed by abdominal ultrasound and risk factors
were analyzed by a multivariate logistic regression model.
Results
Cholecystectomy was performed in 5/114 (4.3%), asymptomatic gall-
stones were seen in 16/114 (14%), and symptomatic gallstones except
for patients after cholecystectomy were seen in 7/114 (6.1%). In group
A, 4 patients (27%) with gallstones underwent cholecystectomy
(p b 0.01). Non-cholesterol gallstones were observed in 5 patients
(33%) in group A, 12 patients (29%) in group B, nobody in group C, and
3 patients (8.6%) in group D. By a multivariate logistic regression model,
7EditorialCCHD by nature regardless of repair, prolonged cyanosis periods, higher
frequency of cardiopulmonary bypass (CPB), and lower platelet counts
were signiﬁcant factors predicting gallstones (odds ratio 4.48, 1.08, 3.96,
and 0.87, 95% CI, 1.14–17.5, 1.00–1.18, 1.65–9.54, and 0.75–0.99,
respectively).
Conclusion
The prevalence of cholelithiasis and asymptomatic gallstones is signif-
icantly high in CCHD patients regardless of cardiac repairs. CCHD by na-
ture, prolonged cyanosis durations, high frequency of CPB and low
platelet counts have inﬂuences ongallstone formation in adultswithCHD.
Mortality in adult congenital heart disease: are national registries
reliable for cause of death?
Background
Statistics on cause-speciﬁcmortality are important for prognostic re-
search. The aim of this study was to assess the utility of the national
mortality registry in research on causes of death in adult patients with
congenital heart disease (CHD).
Methods
The CONCOR registry of over 10,000 adults with CHD was used to
verify the causes of death provided by the WHO guidelines based na-
tional mortality registry, by linkage.
Results
Of 7277 patients linked to the national mortality registry, 196 (2.4%)
were recorded deceased, versus 228 deceased patients (3.1%) recorded
in the CONCOR registry, during a follow-up of 25,900 patient years. Medi-
an age at death was 48.9 years. Of all deaths in the CONCOR registry, 77%
had a cardiovascular origin; nearly 50%were due to progressive heart fail-
ure and arrhythmias. The national mortality registry recorded death due
to progressive heart failure and arrhythmias in only 8.5%. Moreover, this
registry recorded death with an ‘unspeciﬁed’ cause in approximately
30%, primarily containing patients who died due to progressive heart fail-
ure and arrhythmias according to their medical records.
Conclusion
WHOguidelines based nationalmortality registries lack the speciﬁc-
ity and completeness needed for accurate research on causes of death in
adult patients with CHD [19].
Prediction of complications in pregnant women with cardiac
diseases referred to a tertiary center
Background
Prediction of adverse maternal and neonatal events in women with
heart disease is not well established. We aimed to assess cardiac, obstet-
rical and neonatal complications in pregnant women with heart disease
referred to our tertiary care center and validate a previously proposed
risk index.
Methods
We included 227womenwith cardiac disease followed for 312preg-
nancies at our tertiary center from 1992 to 2007. Cardiac risk was
assessed using the previously proposed Cardiac Disease in Pregnancy
(CARPREG) score and its association with maternal and neonatal out-
comes was determined.Results
Maternal cardiac lesions were predominantly congenital (81.4%).
CARPREG risk was low (score = 0) in 66.3% and intermediate
(score = 1) in 33.7% pregnancies. Maternal cardiac events complicated
7.4% pregnancies, with pulmonary edema occurring most frequently
(3.8%). An intermediate scorewas associatedwith a higher rate of cardi-
ac events (19.0% vs. 1.4%, odds ratio [OR] 15.6, 95% conﬁdence interval
(95%CI) 4.5–54.4, p b 0.0001). Adverse events occurred in 27.5% neo-
nates. Preterm deliveries occurred in 16.7% pregnancies, more com-
monly in patients with intermediate scores (OR 2.4, 95%CI 1.2–4.6,
p = 0.01). The sensitivity and negative predictive values of a low
score were respectively 87% and 99% for total cardiac events and both
100% for primary cardiac events including pulmonary edema and
sustained arrhythmia.Conclusion
The CARPREG risk index has a high sensitivity and negative predic-
tive value with regards to cardiac complications in pregnant women
with heart disease. It may, therefore, be routinely used to improve the
assessment of cardiac risk before and during pregnancy [20].Pulmonary valve replacement in chronic pulmonary regurgitation
in adults with congenital heart disease: impact of preoperative
QRS-duration and NT-proBNP levels on postoperative right
ventricular function
Background
Chronic severe pulmonary regurgitation (PR) causes progressive
right ventricular (RV) dysfunction and heart failure. Parameters deﬁn-
ing the optimal time point for surgery of chronic PR are lacking. The
present study prospectively evaluated the impact of preoperative clin-
ical parameters, cardiorespiratory function, QRS duration and NT-
proBNP levels on post operative RV function and volumes assessed
by cardiac magnetic resonance imaging (CMR) in patients with chronic
severe PR undergoing pulmonary valve replacement.Methods and results
CMR was performed pre- and 6 months postoperatively in 27 pa-
tients (23.6 ± 2.9 years, 15 women) with severe PR. Postoperatively,
RV endsystolic (RVESVI) and enddiastolic volume indices (RVEDVI)
decreased signiﬁcantly (RVESVI pre 78.2 ± 20.4 mL/m2 BSA vs.
RVESVI post 52.2 ± 16.8 mL/m2BSA, p b 0.001; RVEDVI pre 150.7 ±
27.7 mL/m2BSA vs. RVEDVI post 105.7 ± 26.7 mL/m2BSA; p b 0,001).
With increasing preoperative QRS-duration, postoperative RVEF de-
creased signiﬁcantly (r = −0.57; p b 0.005). Preoperative QRS-
duration smaller than the median (156 ms) predicted an improved
RVEF compared to QRS-duration ≥156 ms (54.9% vs 46.8%, p b 0.05).
Multivariate analysis identiﬁedpreoperativeQRSduration as an indepen-
dent predictor of postoperative RVEF (p b 0.005). NT-proBNP levels cor-
related with changes in RVEDI (r = 0.58 p b 0.005) and RVESVI
(r = 0.63; p b 0.0001).Multivariate analysis identiﬁedNT-proBNP levels
prior to PVR as an independent predictor of volume changes (p b 0.05).Conclusion
Valve replacement in severe pulmonary regurgitation causes signif-
icant reduction of RV volumes. Both, preoperative NT-proBNP level ele-
vation and QRS prolongation indicate patients with poorer outcome
regarding RV function and volumes [21].
8 EditorialReplacement therapy for iron deﬁciency improves exercise capacity
and quality of life in patients with cyanotic congenital heart disease
and/or the Eisenmenger syndrome
Introduction
Iron deﬁciency is common in cyanotic congenital heart disease
(CHD) and results in reduced exercise tolerance. Currently, iron re-
placement is advocated with limited evidence in cyanotic CHD. We in-
vestigated the safety and efﬁcacy of iron replacement therapy in this
population.
Methods
Twenty-ﬁve iron-deﬁcient cyanotic CHD patients were prospective-
ly studied between August 2008 and January 2009. Oral ferrous fuma-
rate was titrated to a maximum dose of 200 mg thrice-daily. The
CAMPHOR QoL questionnaire, 6 minute walk test (6MWT) and cardio-
pulmonary exercise testing were conducted at baseline and after
3 months of treatment.
Results
Mean age was 39.9 ± 10.9 years, 80% females. Fourteen had
Eisenmenger syndrome, 6 complex cyanotic disease and 5 Fontan circula-
tion. There were no adverse effects necessitating termination of treat-
ment. After 3 months of treatment, hemoglobin (19.0 ± 2.9 g/dL to
20.4 ± 2.7 g/dL, p b 0.001), ferritin (13.3 ± 4.7 μg/L to 54.1 ±
24.2 μg/L, p b 0.001) and transferrin saturation (17.8 ± 9.6% to
34.8 ± 23.4%, p b 0.001) signiﬁcantly increased. Signiﬁcant improve-
ments were also detected in the total CAMPHOR score (20.7 ± 10.9 to
16.2 ± 10.4, p = 0.001) and 6MWT distance (371.7 ± 84.7 m to
402.8.0 ± 74.9 m, p = 0.001). Peak VO(2) remained unchanged
(40.7 ± 9.2% to 43.8 ± 12.4% of predicted, p = 0.15).
Conclusion
Threemonths of iron replacement therapy in iron-deﬁcient cyanotic
CHD patients was safe and resulted in signiﬁcant improvement in exer-
cise tolerance and quality of life. Identiﬁcation of iron deﬁciency and ap-
propriate replacement should be advocated in these patients [22].
Long-term prognostic value of cardiac autonomic nervous activity
in postoperative patients with congenital heart disease
Background
Abnormal cardiac autonomic nervous activity (CANA) is not uncom-
mon in postoperative patients with congenital heart disease (CHD).
Methods and results
We attempted to clarify the prognostic value of the CANA
variables in postoperative CHD patients and prospectively evaluated
the CANA variables in 292 consecutive biventricular and 91
Fontan repair patients. The CANA variables included the heart rate
variability, arterial baroreﬂex sensitivity (BRS), washout ratio of
the myocardial metaiodobenzylguanidine scintigraphy, and plasma
norepinephrine level. With a follow-up of 10 ± 2 years, 98 total events
that required hospitalization, including 13 deaths and 48 unscheduled
cardiac events (UCEs), occurred. In all the CHDpatients, all the CANA in-
dices predicted the total events and UCEs. Of those, the NE level
(p = 0.0004) and BRS (p = 0.0373) predicted the mortality. In a mul-
tivariate analysis, the BRS was an independent CANA-predictor for the
total events (p = 0.007). In the biventricular patients, the plasma NE
level, heart rate variability, and BRS predicted the total events andUCEs and the BRS was the only independent CANA-predictor for the
total events (p = 0.0329). In the Fontan patients, the plasma NE level
was the only predictor for the UCEs (p = 0.0242) and no other CANA
variables were independent predictors of the total events or UCEs.
Conclusions
All CANA variables, especially the BRS, were useful predictors for fu-
ture clinical events in biventricular CHDpatients, whereas noCANA var-
iables, except for the plasma NE level, predicted future clinical events in
the Fontan patients [23].
Pathophysiology of coronary blood ﬂow in congenital heart disease
Objectives
The aim was to investigate the effects of volume and pressure over-
load and increased coronary perfusion pressure on coronary ﬂow (CF)
in congenital heart disease (CHD) patients.
Background
The effects of CHD on CF are poorly mapped.
Methods
A total of 65 patients with acyanotic CHD and 49 age-matched
healthy controls were examined by transthoracic Doppler echocardiog-
raphy. Posterior descending artery ﬂow was measured in patients with
pulmonary valve stenosis (PS) and atrial septal defects (ASDs) i.e. in le-
sions with right ventricular pressure or volume overload, and left anteri-
or descending artery ﬂow in patientswith Coarctation of the Aorta (CoA)
and ventricular septal defect (VSD), in lesions with left ventricular pres-
sure or volume overload. The CF data in each patient group were
expressed as the percent of the median for healthy controls from the
same age group.
Results
The CF values were in VSD 172%, ASD 185%, PS 233%, and CoA 773%
patients. In CoA patients body surface area (r = 0.90, p b 0.0001), sys-
tolic blood pressure (r = 0.72, p b 0.0001), diastolic blood pressure
(r = 0.77, p b 0.0001), systolic wall tension (r = −0.77, p = 0.004),
and signs of inﬂammation (log CRP, r = −0.75, p = 0.007) correlated
with CF.
Conclusions
The increase in CF and velocity was most signiﬁcant in patients with
CoA. In newborns, increased coronary perfusion pressure seems to be
themost important factor for increased CF, even if thepressure is not as-
sumed to cause a signiﬁcant increase in ﬂow over the auto-regulatory
range of 70–130 mm Hg. We also showed that inﬂammation decreases
CF [24].
Emergency admissions in Asians with adult congenital heart disease
Background and aim
In the area of acute emergency care, the needs of adult congenital
heart disease patients (ACHD) are unique and burden on hospital re-
sources are likely substantial. We aim to understand the reasons for
emergency admissions and associations of increased hospital length of
stay (LOS).
9EditorialMethods
We evaluated 600 ACHD patients in our adult congenital database.
Patients who required emergency admissions between January 2007
and December 2007 were studied from hospital records.
Results
Sixty-eight ACHD patients (11%) required emergency admissions,
culminating in a total of 108 admissions. Mean age was 37.6 years (SD
18.0), with a female preponderance (56%). Most were either schooling
or working (62%) andwere single (62%). Atrial septal defect (24%), ven-
tricular septal defect (19%) and Tetralogy of Fallot (13%) formed thema-
jority of diagnoses, mirroring proportions in our cohort. A third of the
admissions were for cardiac reasons including arrhythmia, heart failure,
endocarditis, and thromboembolism; the remaining two-thirds were
for non-cardiac reasons. Median hospital LOS was 5.0 days. Those who
were older (p = 0.02) and neither employed nor schooling
(p = 0.021) had longer LOS. Thromboembolism accounted for longer
LOS (p = 0.047). One-third of the admissions that required interdisci-
plinary referrals had increased LOS (p b 0.001), with utilization of
non-cardiac investigations (p = 0.002). Increased LOS was not associ-
ated with adverse clinical outcome (p = 0.68).
Conclusions
ACHD patients require emergency admissions for both cardiac
and non-cardiac reasons. Older age groups, unemployment and
thromboembolic complications were associated with increased
LOS. Non-cardiac conditions required interdisciplinary resources
and were associated with increased LOS. Understanding their di-
verse acute needs may potentially improve care and outcome for
these patients [25].
Acute hemodynamic responses to adenosine and iloprost in
patients with congenital heart defects and severe pulmonary
arterial hypertension
Background
Detection of pulmonary vasoreactivity is important for the evalua-
tion of patientwithpulmonary arterial hypertension (PAH). The present
study aimed to investigate the acute hemodynamic responses to aden-
osine and iloprost in patients with congenital heart defects (CHDs)
and severe PAH.
Patients and methods
FromMar 2007 to Nov 2009, 75 patients with severe PAH secondary
to left-to-right shunt CHDs underwent acute vasodilator test using aero-
solized iloprost (n = 50) or intravenous adenosine (n = 25). The he-
modynamics were detected and analyzed.
Results
Decreased mean pulmonary arterial pressure (PAP) and pulmonary
vascular resistance (PVR) were observed in 39 and 43 patients in the
iloprost group, and in 16 and 19 patients in the adenosine group, respec-
tively. However, the mean PAP was higher than 40 mm Hg in both
groups. No signiﬁcant difference was observed in the age and baseline
hemodynamics between the patients with the decrease of PVR and
mean pulmonary-to-aortic pressure (Pp/Ps) ratio greater than 10%
and the remaining patients. Adenosine decreased both PAP and system-
ic arterial pressure signiﬁcantly, while iloprost inhalation selectively re-
duced the PAP and increased the oxygen saturation of femoral arterial
blood and the pulmonary-to-systemic ﬂow (Qp/Qs) ratio. Comparedwith adenosine, iloprost caused a more profound decline in the Pp/Ps
ratio, PVR and pulmonary-to-systemic vascular resistance ratio, and in-
crease in the Qp/Qs ratio.
Conclusions
The acute haemodynamic responses to adenosine and iloprost var-
ied among the patients with CHDs and severe PAH. Different to adeno-
sine, inhaled iloprost exerted selective pulmonary vasodilative effects
and was beneﬁcial for pulmonary gas exchange [26].
Recommendations for adult and pediatric cardiologists on
obtaining additional qualiﬁcation in “Adults with Congenital Heart
Disease” (ACHD)
Background
The number of adult congenital heart disease (ACHD) patients will
be larger in the medium to long term than that of children and adoles-
cents with congenital heart disease. The present structures for themed-
ical care of ACHD patients are not sufﬁcient and need to be improved.
Therefore the Task Force aimed at developing recommendations for
adult and pediatric cardiologists to acquire the additional qualiﬁcation
“Adults with Congenital Heart Disease” (ACDH).
Methods
The members of the interdisciplinary Task Force were selected on
the basis of their special clinical, scientiﬁc and organizational expertise.
The leading author submitted a draft version, which was revised by a
sub-group of the interdisciplinary Task Force. It was subsequently
agreed upon and re-circulated by all the members of the Task Force.
The recommendations were then presented to the relevant committees
of all participating associations and groups and approved following de-
tailed discussion.
Results
A training program for acquiring an additional qualiﬁcation in
the treatment of adults with congenital heart disease was created
successfully.
Conclusions
The medical care of adults with congenital heart disease is a sub-
speciality in the border area between adult cardiology and pediatric car-
diology. ACHD cardiologists are to be specially trained experts with ap-
propriate knowledge and special skills and experience in the diagnosis
and therapy of congenital heart disease in adults. ACHD cardiologists
should be able to recognize and treat problems that occur in adulthood
in connection with congenital heart disease [27].
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